SBIR-STTR Award

Anti retroviral activity of marine algae
Award last edited on: 3/25/02

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$50,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Bruce W Harger

Company Information

Neushul Matriculture Inc

475 Kellogg Way
Goleta, CA 93117
   (805) 964-5844
   N/A
   N/A
Location: Single
Congr. District: 24
County: Santa Barbara

Phase I

Contract Number: 1R43CA042677-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1986
Phase I Amount
$50,000
Retroviruses are a relatively newly recognized group of RNA viruses. Many are asociated with malignancies in mammals, and the virus that has been identified in cases of acquired immune deficiency syndrome (AIDS) is a retrovirus. Due to the severity of AIDS, it has been placed at the top of the nations's health priorities. Antiviral agents are being sought to treat cases of AIDS and other retroviral infections.In the course of testing marine algae for antiviral activity, it was found that one particular alga showed significant in vitro activity against the leukemia virus, a retrovirus. The goal of the proposed research is to determine if this in vitro activity will be useful to treat - retrovirusassociated disease in humans. The objectives of the Phase I research are to establish the nature and magnitude of the antiviral activity of this alga by using several in vitro assays. In addition, the active agent(s) will be purified and identified. The first stages of this work will involve determining what type of compound is responsible for this activity and then separating it from the crude algal extracts. Characterization of the agent(s) involved will also provide information useful in hypothesizing a mechanism of action.National Cancer Institute (NCI)

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----